Table 13.

Recommendations for the management of hypertension with chronic kidney disease. ACEi: Angiotensin-converting enzyme inhibitor; ARB: Angiotensin-receptor blocker; BP: blood pressure.

Class	Recommendation
	An ACEi or an ARB is recommended for the first line management of people with hypertension and proteinuric chronic kidney disease (urinary protein level > 150 mg in 24 hours or albumin to creatinine ratio > 30 mg/mmol).
	A treatment target of SBP 130–140 mmHg is recommended in people with hypertension and CKD
	If needed, combination therapy should be considered to achieve BP targets.
	The combination of an ACEi and ARB is not recommended.